Team:WHU-China/Safety

Brief Answers to the Questions

Welcome to our Safety Page. We will first answer the safety questions asked by iGEM headquarters briefly, and then discuss safety issues associated with our project in detail. As well, we will report our ideas and practice on guaranteeing and developing biosafety.

Q1. Would any of your project ideas raise safety issues in terms of: Researcher safety, public safety, or environmental safety?
No. Our design is based on the commonly used E. coli K.12 strain and genes we manipulated are original genes contained in E. coli The protein products, at least from current understanding, will cause no harm to researchers, the public and environment. In addition, strict lab practice is executed to further ensure the safety.

Q2. Do any of the new BioBrick parts (or devices) that you made this year raise any safety issues? If yes,
Did you document these issues in the Registry?
How did you manage to handle the safety issue?
How could other teams learn from your experience?
Yes, we will discuss this question in latter part of this page (Safety Considerations of Our Biobrick parts and Our Project).

Q3. Is there a local biosafety group, committee, or review board at your institution? If yes, what does your local biosafety group think about your project? If no, which specific biosafety rules or guidelines do you have to consider in your country?
Yes. All materials obtained have received the approvals from the department's laboratory management committees. We are also obliged to observe the regulations of Scientific Training Room and apply for approval for materials before we start our project.

Q4. Do you have any other ideas how to deal with safety issues that could be useful for future iGEM competitions? How could parts, devices and systems be made even safer through biosafety engineering?
Some classified measures should be taken according to the safety of the material. For example, plasmids that may harm the safety, when submitted, should receive more attention and have a stricter package. Some harmful byproducts of researches should be eliminated after the competition if without further value for researches.
We have done our human practice aiming at publicizing biosafety ideas to the public, which is what we are really inclined to popularize to other teams for future iGEM competitions.

这是第二篇

这是一段passage，后面是换行
这是新的一行
这是第二行

这是二段passage

这是第三篇

这是一段passage，后面是强调的 这是强调的样式

这是一张图片

这是图片的描述，这是下一段，这是下一段，这是下一段，这是下一段，这是下一段，这是下一段，这是下一段，这是下一段，这是下一段，这是下一段，这是下一段，这是下一段，这是下一段，这是下一段，这是下一段，这是下一段，这是下一段，这是下一段，这是下一段，这是下一段，这是下一段，这是下一段，这是下一段，这是下一段，这是下一段，这是下一段，这是下一段，这是下一段，这是下一段，这是下一段，这是下一段，这是下一段，这是下一段，这是下一段，这是下一段，这是下一段，这是下一段

这是第四篇

下面是list列表：

• 这是第一项
• 这是第二项
• 这是第三项